نتائج البحث - Rahul Banerjee

  • يعرض 1 - 14 نتائج من 14
تنقيح النتائج
  1. 1
    Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling

    Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profiling حسب Rahul Banerjee, Kara I. Cicero, Sarah S. Lee, Andrew J. Cowan

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel

    Disparities in relapsed or refractory multiple myeloma: recommendations from an interprofessional consensus panel حسب Rahul Banerjee, Yelak Biru, Craig E. Cole, Beth Faiman, Shonali Midha, Sikander Ailawadhi

    منشور في 2024
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Effects of Initial Graft Tension on the Tibiofemoral Compressive Forces and Joint Position after Anterior Cruciate Ligament Reconstruction

    Effects of Initial Graft Tension on the Tibiofemoral Compressive Forces and Joint Position after Anterior Cruciate Ligament Reconstruction حسب Mark F. Brady, Michael P. Bradley, Braden C. Fleming, Paul D. Fadale, Michael J. Hulstyn, Rahul Banerjee

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Comparable outcomes in chronic lymphocytic leukaemia (<scp>CLL</scp>) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study

    Comparable outcomes in chronic lymphocytic leukaemia (<scp>CLL</scp>) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study حسب Anthony R. Mato, Colleen Timlin, Chaitra S. Ujjani, Alan P Skarbnik, Christina Howlett, Rahul Banerjee, Chadi Nabhan, Stephen J. Schuster

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma

    Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma حسب Kevin Reyes, Yen‐Chun Liu, Chiung‐Yu Huang, Rahul Banerjee, T. John Martin, Sandy W. Wong, Jeffrey L. Wolf, Shagun Arora, Nina Shah, Ajai Chari, Alfred Chung

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis

    Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis حسب Fieke W. Hoff, Rahul Banerjee, Adeel Khan, Georgia McCaughan, Bo Wang, Xiaoliang Wang, James Roose, Larry D. Anderson, Andrew J. Cowan, S. Vincent Rajkumar, Gurbakhash Kaur

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma

    Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma حسب Kevin Reyes, Chiung‐Yu Huang, Mimi Lo, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey L. Wolf, Rebecca L. Olin, Thomas G. Martin, Nina Shah, Rahul Banerjee

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma

    Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma حسب Rahul Banerjee, Jeffrey Marsal, Chiung‐Yu Huang, Mimi Lo, Swetha Kambhampati Thiruvengadam, Vanessa E. Kennedy, Shagun Arora, Jeffrey L. Wolf, Thomas G. Martin, Sandy W. Wong, Nina Shah

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis

    Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis حسب Sharlene Dong, Rahul Banerjee, Adeel Khan, Mengru Wang, Xiaoliang Wang, Anosheh Afghahi, Aimaz Afrough, Murali Janakiram, Bo Wang, Andrew J. Cowan, Adam S. Sperling, Larry D. Anderson, S. Vincent Rajkumar, Gurbakhash Kaur

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Answering the “Doctor, can CAR-T therapy cause cancer?” question in clinic

    Answering the “Doctor, can CAR-T therapy cause cancer?” question in clinic حسب Rahul Banerjee, Christina Poh, Alexandre V. Hirayama, Jordan Gauthier, Ryan D. Cassaday, Mazyar Shadman, Andrew J. Cowan, Brian G. Till, Damian J. Green, Hans‐Peter Kiem, Ajay K. Gopal, David G. Maloney

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium

    Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium حسب Yucai Wang, Preetesh Jain, Frederick L. Locke, Matthew J. Maurer, Matthew J. Frank, Javier Muñoz, Saurabh Dahiya, Amer Beitinjaneh, Miriam T. Jacobs, Joseph P. McGuirk, Julie M. Vose, André Goy, Charalambos Andreadis, Brian T. Hill, Kathleen A. Dorritie, Olalekan O. Oluwole, Abhinav Deol, Jonas Paludo, Bijal Shah, Trent Wang, Rahul Banerjee, David B. Miklos, Aaron P. Rapoport, Lazaros J. Lekakis, Armin Ghobadi, Sattva S. Neelapu, Yi Lin, Michael Wang, Michael D. Jain

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma

    International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma حسب Luciano J. Costa, Rahul Banerjee, Hira Mian, Katja Weisel, Susan Bal, Benjamin A. Derman, Myo Htut, Chandramouli Nagarajan, Cesar Rodriguez, Joshua Richter, Matthew J. Frigault, Jing C. Ye, Niels W.C.J. van de Donk, Peter M. Voorhees, Benjamin Puliafito, Nizar J. Bahlis, Rakesh Popat, Wee Joo Chng, P. Joy Ho, Gurbakhash Kaur, Prashant Kapoor, Juan Du, Fredrik Schjesvold, Jesús G. Berdeja, Hermann Einsele, Adam D. Cohen, Joseph Mıkhael, Yelak Biru, S. Vincent Rajkumar, Yi Lin, Thomas G. Martin, Ajai Chari

    منشور في 2025
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma

    Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma حسب Gliceida Galarza Fortuna, Rahul Banerjee, Constanza Savid-Frontera, Jinming Song, Carlos Moran Segura, Jonathan V. Nguyen, Lazaros J. Lekakis, Sebastian Fernandez‐Pol, Annie N. Samraj, Kikkeri N. Naresh, Mariola A Vazquez-Martinez, Rachid Baz, Jay Y. Spiegel, Lekha Mikkilineni, John Gubatan, Surbhi Sidana, Andre De Menezes Silva Corraes, Nilesh Kalariya, Krina K. Patel, Kevin G. Shim, Rafaël Fonseca, Christopher Ferreri, Peter M. Voorhees, Shambavi Richard, Cesar Rodriguez Valdes, Sireesha Asoori, Jeffrey L. Wolf, Andrew J. Cowan, Douglas W. Sborov, Frederick L. Locke, Yi Lin, Yinghong Wang, Doris K. Hansen

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

    Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis حسب Brittany Knick Ragon, Mithun Vinod Shah, Anita D’Souza, Noel Estrada‐Merly, Lohith Gowda, Gemlyn George, Marcos de Lima, Shahrukh K. Hashmi, Mohamed A. Kharfan‐Dabaja, Navneet S. Majhail, Rahul Banerjee, Ayman Saad, Gerhard Hildebrandt, Hira Mian, Muhammad Bilal Abid, Minoo Battiwalla, Lazaros J. Lekakis, Sagar S. Patel, Hemant S. Murthy, Yago Nieto, Christopher Strouse, Sherif M. Badawy, Samer Al Hadidi, Bhagirathbhai Dholaria, Mahmoud Aljurf, David H. Vesole, Cindy H. Lee, Attaphol Pawarode, Usama Gergis, Kevin C. Miller, Leona Holmberg, Aimaz Afrough, Melhem Solh, Pashna N. Munshi, Taiga Nishihori, Larry D. Anderson, Baldeep Wirk, Gurbakhash Kaur, Muzaffar H. Qazilbash, Nina Shah, Shaji Kumar, Saad Z. Usmani

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: